FDA Inspection
Dr. Rubin H. SaavedraDr. Rubin H. Saavedra – FDA Inspection, Mar 25, 2009
Record Details
This FDA Inspection record concerns Dr. Rubin H. Saavedra, with an inspection on March 25, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Dr. Rubin H. Saavedra
- Inspection Date
- March 25, 2009
- Product Type
- Drugs
View Company Profile
ID · 7e95a411-c315-4763-be8f-d8ecc56b5e33
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 577820
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.64(b)Safety reports
- 21 CFR 312.62(a)Accountability records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dr. Rubin H. Saavedra
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 16, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 19, 2011 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Dr. Rubin H. Saavedra
- FDA Inspection 1017391 - 2017-06-16
- FDA Inspection 727733 - 2011-05-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.